Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV: Safety Overview

Metric TISLELIZUMAB TISOTUMAB VEDOTIN-TFTV
Total FAERS Reports 4,996 560
Deaths Reported 114 39
Death Rate 2.3% 7.0%
Hospitalizations 2,586 76
Average Patient Age 62.9 yrs 53.3 yrs
% Female Patients 26.5% 99.6%
Manufacturer BeOne Medicines USA, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription